Detalhe da pesquisa
1.
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.
Cell
; 184(15): 3936-3948.e10, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192529
2.
A vaccine-induced public antibody protects against SARS-CoV-2 and emerging variants.
Immunity
; 54(9): 2159-2166.e6, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464596
3.
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron.
Nature
; 602(7898): 682-688, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35016197
4.
An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody.
mBio
; 15(1): e0247723, 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38054729
5.
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination.
bioRxiv
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464151
6.
An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies.
bioRxiv
; 2023 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37131698
7.
Structure of a Vaccine-Induced, Germline-Encoded Human Antibody Defines a Neutralizing Epitope on the SARS-CoV-2 Spike N-Terminal Domain.
mBio
; 13(3): e0358021, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467422
8.
The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD.
medRxiv
; 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758878
9.
A public vaccine-induced human antibody protects against SARS-CoV-2 and emerging variants.
bioRxiv
; 2021 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33791696